Elevai Labs Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Net Income	-4.3	-1.8	-0.78
Depreciation & Amortization	0.01	0.01	0
Share-Based Compensation	0.49	0.17	0.14
Other Operating Activities	-0.75	0.04	-0.02
Operating Cash Flow	-4.56	-1.59	-0.66
Capital Expenditures	-0.01	-0.03	-0.03
Investing Cash Flow	-0.01	-0.03	-0.03
Share Issuance / Repurchase	7.5	0.03	0
Debt Issued / Paid	0	0.18	0
Other Financing Activities	-0.76	2.15	1.09
Financing Cash Flow	6.74	2.36	1.09
Exchange Rate Effect	0	-0	0
Net Cash Flow	2.17	0.74	0.4
Free Cash Flow	-4.57	-1.62	-0.69
Free Cash Flow Margin	-266.73%	-211.14%	-83847.16%
Free Cash Flow Per Share	-0.42	-0.17	-0.07

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).